Glutathione S-transferase P

AltitudeomicsDB
Protein Official symbol GSTP1
Aliases GSTP1 FAEES3 GST3
Chromosomal Location  11 
Length 210
Uniprot ID P09211
EC number 2.5.1.18
Protein family Information(Pfam) PF14497;PF02798;
PDB id 10GS;11GS;12GS;13GS;14GS;16GS;17GS;18GS;19GS;1AQV;1AQW;1AQX;1EOG;1EOH;1GSS;1KBN;1LBK;1MD3;1MD4;1PGT;1PX6;1PX7;1ZGN;20GS;22GS;2A2R;2A2S;2GSS;2J9H;2PGT;3CSH;3CSI;3CSJ;3DD3;3DGQ;3GSS;3GUS;3HJM;3HJO;3HKR;3IE3;3KM6;3KMN;3KMO;3N9J;3PGT;4GSS;4PGT;5DAK;5DAL;5DCG;5DDL;5DJL;5DJM;5GSS;5J41;5JCW;5L6X;5X79;6AP9;6GSS;6Y1E;7GSS;8GSS;9GSS;
InterPro ID IPR010987;IPR036282;IPR040079;IPR004045;IPR004046;IPR003082;IPR036249;
dbSNP rs1695 rs1138272 rs41462048

Protein Protein Interaction

0%
Download Tab separated file
AltitudeomicsDB
Protein 1 Protein 2 Combine Score
EPHX1 CYP1A1 0.986
GSTP1 PRDX6 0.967
EPHX1 GSTP1 0.94
GSTP1 GSTT2B 0.923
GSTP1 GGH 0.914
GSTP1 CYP1A1 0.908
GSTT2B GGH 0.904
PRDX6 GGH 0.903
Gene Ontology Semantic Similarity
Download Tab separated file
# 2947 (GSTM3) 2876 (GPX1) 2052 (EPHX1) 2877 (GPX2) 2936 (GSR) 2879 (GPX4) 2939 (GSTA2) 2878 (GPX3) 2948 (GSTM4) 2882 (GPX7) 1557 (CYP2C19) 1571 (CYP2E1) 27306 (HPGDS) 1576 (CYP3A4) 1543 (CYP1A1) 2944 (GSTM1) 2949 (GSTM5) 1544 (CYP1A2) 2678 (GGT1) 728441 (GGTLC3) 91227 (GGTLC2) 92086 (GGTLC1) 2880 (GPX5) 1558 (CYP2C8) 2687 (GGT5) 493869 (GPX8) 1545 (CYP1B1) 4257 (MGST1) 4258 (MGST2) 1555 (CYP2B6) 1548 (CYP2A6) 1553 (CYP2A13) 653689 (GSTT2B) 2938 (GSTA1) 8836 (GGH) 221357 (GSTA5) 4259 (MGST3) 119391 (GSTO2) 9446 (GSTO1) 126 (ADH1C) 2946 (GSTM2) 130 (ADH6) 29785 (CYP2S1) 218 (ALDH3A1) 1559 (CYP2C9) 1572 (CYP2F1) 222 (ALDH3B2) 1562 (CYP2C18) 2937 (GSS) 2940 (GSTA3)
2947 (GSTM3) 1.00 0.39 0.16 0.24 0.23 0.59 0.76 0.55 0.96 0.51 0.49 0.48 0.69 0.41 0.48 0.97 0.83 0.47 0.54 0.40 0.40 0.40 0.23 0.32 0.40 0.27 0.36 0.69 0.65 0.36 0.49 0.34 1.00 0.39 0.16 1.00 0.65 0.73 0.62 0.17 0.88 0.23 0.50 0.44 0.37 0.35 0.16 0.37 0.72 1.00
2876 (GPX1) 0.39 1.00 0.18 0.62 0.30 0.78 0.46 0.72 0.43 0.79 0.45 0.44 0.37 0.39 0.48 0.37 0.48 0.42 0.39 0.20 0.20 0.20 1.00 0.34 0.20 0.89 0.39 0.72 0.64 0.38 0.39 0.34 0.23 0.59 0.17 0.23 0.75 0.53 0.49 0.28 0.59 0.27 0.48 0.42 0.42 0.40 0.27 0.41 0.37 0.23
2052 (EPHX1) 0.16 0.18 1.00 0.21 0.19 0.18 0.22 0.18 0.17 0.21 0.24 0.24 0.17 0.21 0.24 0.17 0.20 0.25 0.23 0.20 0.20 0.20 0.20 0.20 0.20 0.23 0.22 0.21 0.22 0.22 0.17 0.18 0.24 0.23 0.31 0.24 0.22 0.25 0.26 0.20 0.17 0.17 0.20 0.19 0.25 0.23 0.20 0.24 0.13 0.24
2877 (GPX2) 0.24 0.62 0.21 1.00 0.69 0.64 0.29 0.55 0.25 0.65 0.38 0.38 0.25 0.34 0.38 0.23 0.29 0.49 0.25 0.21 0.21 0.21 1.00 0.32 0.21 0.89 0.36 0.58 0.53 0.35 0.29 0.31 0.23 0.62 0.19 0.23 0.63 0.39 0.39 0.30 0.42 0.27 0.34 0.32 0.40 0.37 0.30 0.38 0.22 0.23
2936 (GSR) 0.23 0.30 0.19 0.69 1.00 0.32 0.27 0.34 0.25 0.38 0.32 0.31 0.24 0.28 0.31 0.22 0.28 0.44 0.24 0.21 0.21 0.21 0.37 0.27 0.21 0.42 0.31 0.33 0.32 0.30 0.26 0.28 0.23 0.30 0.19 0.23 0.35 0.43 0.43 0.24 0.28 0.23 0.29 0.27 0.33 0.31 0.24 0.32 0.22 0.23
2879 (GPX4) 0.59 0.78 0.18 0.64 0.32 1.00 0.52 0.80 0.53 0.84 0.48 0.48 0.46 0.42 0.52 0.48 0.66 0.45 0.44 0.20 0.20 0.20 1.00 0.36 0.20 0.89 0.42 0.77 0.68 0.41 0.44 0.38 0.23 0.60 0.17 0.23 0.79 0.65 0.53 0.28 0.69 0.29 0.53 0.46 0.45 0.42 0.28 0.43 0.51 0.23
2939 (GSTA2) 0.76 0.46 0.22 0.29 0.27 0.52 1.00 0.65 0.81 0.55 0.47 0.47 0.70 0.39 0.51 0.75 0.96 0.45 0.60 0.40 0.40 0.40 0.23 0.33 0.40 0.27 0.41 0.85 0.75 0.40 0.45 0.38 1.00 0.60 0.20 1.00 0.75 0.77 0.69 0.21 0.75 0.26 0.54 0.45 0.40 0.38 0.22 0.41 0.52 1.00
2878 (GPX3) 0.55 0.72 0.18 0.55 0.34 0.80 0.65 1.00 0.62 0.85 0.55 0.55 0.54 0.48 0.60 0.51 0.67 0.52 0.57 0.20 0.20 0.20 1.00 0.42 0.20 0.89 0.48 0.81 0.73 0.48 0.52 0.45 0.23 0.46 0.17 0.23 0.82 0.66 0.61 0.24 0.74 0.31 0.63 0.55 0.49 0.48 0.24 0.50 0.55 0.23
2948 (GSTM4) 0.96 0.43 0.17 0.25 0.25 0.53 0.81 0.62 1.00 0.56 0.51 0.51 0.74 0.44 0.52 0.98 0.83 0.49 0.58 0.40 0.40 0.40 0.23 0.34 0.40 0.27 0.40 0.74 0.69 0.39 0.51 0.37 1.00 0.39 0.17 1.00 0.69 0.73 0.65 0.17 0.92 0.25 0.55 0.48 0.40 0.38 0.17 0.40 0.72 1.00
2882 (GPX7) 0.51 0.79 0.21 0.65 0.38 0.84 0.55 0.85 0.56 1.00 0.57 0.56 0.48 0.49 0.60 0.47 0.60 0.53 0.48 0.23 0.23 0.23 0.89 0.42 0.23 1.00 0.49 0.80 0.73 0.48 0.50 0.43 0.27 0.60 0.20 0.27 0.86 0.67 0.61 0.33 0.73 0.34 0.58 0.52 0.52 0.49 0.32 0.50 0.49 0.27
1557 (CYP2C19) 0.49 0.45 0.24 0.38 0.32 0.48 0.47 0.55 0.51 0.57 1.00 0.97 0.45 0.78 0.79 0.47 0.49 0.86 0.43 0.36 0.36 0.36 0.56 0.76 0.36 0.62 0.87 0.52 0.51 0.92 0.84 0.84 0.41 0.34 0.24 0.41 0.55 0.68 0.67 0.39 0.56 0.40 0.73 0.56 0.86 0.84 0.38 0.85 0.43 0.41
1571 (CYP2E1) 0.48 0.44 0.24 0.38 0.31 0.48 0.47 0.55 0.51 0.56 0.97 1.00 0.45 0.75 0.79 0.47 0.49 0.86 0.43 0.36 0.36 0.36 0.56 0.75 0.36 0.62 0.86 0.52 0.51 0.91 0.85 0.85 0.41 0.34 0.24 0.41 0.55 0.67 0.67 0.39 0.56 0.40 0.75 0.55 0.83 0.84 0.37 0.84 0.43 0.41
27306 (HPGDS) 0.69 0.37 0.17 0.25 0.24 0.46 0.70 0.54 0.74 0.48 0.45 0.45 1.00 0.44 0.48 0.68 0.73 0.44 0.50 0.40 0.40 0.40 0.23 0.34 0.40 0.27 0.39 0.65 0.61 0.38 0.40 0.36 1.00 0.38 0.17 1.00 0.61 0.66 0.60 0.18 0.70 0.37 0.47 0.43 0.39 0.37 0.17 0.38 0.67 1.00
1576 (CYP3A4) 0.41 0.39 0.21 0.34 0.28 0.42 0.39 0.48 0.44 0.49 0.78 0.75 0.44 1.00 0.85 0.40 0.41 0.76 0.36 0.36 0.36 0.36 0.56 0.79 0.36 0.62 0.66 0.45 0.45 0.65 0.55 0.56 0.41 0.31 0.22 0.41 0.49 0.63 0.62 0.35 0.50 0.43 0.54 0.49 0.78 0.67 0.34 0.66 0.40 0.41
1543 (CYP1A1) 0.48 0.48 0.24 0.38 0.31 0.52 0.51 0.60 0.52 0.60 0.79 0.79 0.48 0.85 1.00 0.45 0.54 0.74 0.46 0.36 0.36 0.36 0.56 0.85 0.36 0.62 0.72 0.56 0.54 0.71 0.57 0.62 0.41 0.35 0.25 0.41 0.58 0.72 0.70 0.40 0.58 0.41 0.65 0.59 0.78 0.75 0.39 0.75 0.47 0.41
2944 (GSTM1) 0.97 0.37 0.17 0.23 0.22 0.48 0.75 0.51 0.98 0.47 0.47 0.47 0.68 0.40 0.45 1.00 0.77 0.45 0.50 0.40 0.40 0.40 0.23 0.30 0.40 0.27 0.35 0.68 0.63 0.35 0.47 0.32 1.00 0.43 0.17 1.00 0.63 0.67 0.59 0.17 0.88 0.23 0.46 0.40 0.36 0.34 0.17 0.35 0.67 1.00
2949 (GSTM5) 0.83 0.48 0.20 0.29 0.28 0.66 0.96 0.67 0.83 0.60 0.49 0.49 0.73 0.41 0.54 0.77 1.00 0.47 0.63 0.40 0.40 0.40 0.23 0.35 0.40 0.27 0.42 0.84 0.76 0.41 0.48 0.39 1.00 0.51 0.19 1.00 0.76 0.83 0.71 0.20 0.77 0.26 0.59 0.49 0.41 0.40 0.20 0.42 0.60 1.00
1544 (CYP1A2) 0.47 0.42 0.25 0.49 0.44 0.45 0.45 0.52 0.49 0.53 0.86 0.86 0.44 0.76 0.74 0.45 0.47 1.00 0.42 0.36 0.36 0.36 0.56 0.71 0.36 0.62 0.82 0.50 0.49 0.77 0.69 0.70 0.41 0.34 0.25 0.41 0.52 0.65 0.64 0.37 0.54 0.38 0.60 0.52 0.79 0.74 0.36 0.70 0.42 0.41
2678 (GGT1) 0.54 0.39 0.23 0.25 0.24 0.44 0.60 0.57 0.58 0.48 0.43 0.43 0.50 0.36 0.46 0.50 0.63 0.42 1.00 1.00 1.00 1.00 0.20 0.30 1.00 0.23 0.37 0.53 0.49 0.36 0.40 0.33 0.40 0.27 0.61 0.40 0.49 0.55 0.48 0.18 0.57 0.23 0.46 0.39 0.37 0.34 0.18 0.36 0.48 0.40
728441 (GGTLC3) 0.40 0.20 0.20 0.21 0.21 0.20 0.40 0.20 0.40 0.23 0.36 0.36 0.40 0.36 0.36 0.40 0.40 0.36 1.00 1.00 1.00 1.00 0.20 0.28 1.00 0.23 0.28 0.40 0.40 0.28 0.21 0.21 0.40 0.40 0.20 0.40 0.40 0.40 0.40 0.20 0.40 0.20 0.21 0.20 0.36 0.28 0.20 0.28 0.20 0.40
91227 (GGTLC2) 0.40 0.20 0.20 0.21 0.21 0.20 0.40 0.20 0.40 0.23 0.36 0.36 0.40 0.36 0.36 0.40 0.40 0.36 1.00 1.00 1.00 1.00 0.20 0.28 1.00 0.23 0.28 0.40 0.40 0.28 0.21 0.21 0.40 0.40 0.20 0.40 0.40 0.40 0.40 0.20 0.40 0.20 0.21 0.20 0.36 0.28 0.20 0.28 0.20 0.40
92086 (GGTLC1) 0.40 0.20 0.20 0.21 0.21 0.20 0.40 0.20 0.40 0.23 0.36 0.36 0.40 0.36 0.36 0.40 0.40 0.36 1.00 1.00 1.00 1.00 0.20 0.28 1.00 0.23 0.28 0.40 0.40 0.28 0.21 0.21 0.40 0.40 0.20 0.40 0.40 0.40 0.40 0.20 0.40 0.20 0.21 0.20 0.36 0.28 0.20 0.28 0.20 0.40
2880 (GPX5) 0.23 1.00 0.20 1.00 0.37 1.00 0.23 1.00 0.23 0.89 0.56 0.56 0.23 0.56 0.56 0.23 0.23 0.56 0.20 0.20 0.20 0.20 1.00 0.45 0.20 0.89 0.45 1.00 1.00 0.45 0.35 0.35 0.23 1.00 0.20 0.23 1.00 0.56 0.56 0.33 1.00 0.33 0.35 0.33 0.56 0.45 0.33 0.45 0.20 0.23
1558 (CYP2C8) 0.32 0.34 0.20 0.32 0.27 0.36 0.33 0.42 0.34 0.42 0.76 0.75 0.34 0.79 0.85 0.30 0.35 0.71 0.30 0.28 0.28 0.28 0.45 1.00 0.28 0.51 0.70 0.38 0.38 0.76 0.58 0.69 0.33 0.29 0.20 0.33 0.41 0.51 0.51 0.34 0.39 0.34 0.63 0.41 0.85 0.80 0.32 0.81 0.31 0.33
2687 (GGT5) 0.40 0.20 0.20 0.21 0.21 0.20 0.40 0.20 0.40 0.23 0.36 0.36 0.40 0.36 0.36 0.40 0.40 0.36 1.00 1.00 1.00 1.00 0.20 0.28 1.00 0.23 0.28 0.40 0.40 0.28 0.21 0.21 0.40 0.40 0.20 0.40 0.40 0.40 0.40 0.20 0.40 0.20 0.21 0.20 0.36 0.28 0.20 0.28 0.20 0.40
493869 (GPX8) 0.27 0.89 0.23 0.89 0.42 0.89 0.27 0.89 0.27 1.00 0.62 0.62 0.27 0.62 0.62 0.27 0.27 0.62 0.23 0.23 0.23 0.23 0.89 0.51 0.23 1.00 0.51 0.89 0.89 0.51 0.39 0.39 0.27 0.89 0.23 0.27 1.00 0.62 0.62 0.38 0.89 0.38 0.39 0.38 0.62 0.51 0.38 0.51 0.23 0.27
1545 (CYP1B1) 0.36 0.39 0.22 0.36 0.31 0.42 0.41 0.48 0.40 0.49 0.87 0.86 0.39 0.66 0.72 0.35 0.42 0.82 0.37 0.28 0.28 0.28 0.45 0.70 0.28 0.51 1.00 0.45 0.43 0.93 0.74 0.87 0.33 0.31 0.22 0.33 0.47 0.55 0.55 0.36 0.43 0.37 0.64 0.47 0.77 0.88 0.34 0.83 0.37 0.33
4257 (MGST1) 0.69 0.72 0.21 0.58 0.33 0.77 0.85 0.81 0.74 0.80 0.52 0.52 0.65 0.45 0.56 0.68 0.84 0.50 0.53 0.40 0.40 0.40 1.00 0.38 0.40 0.89 0.45 1.00 0.90 0.44 0.46 0.40 1.00 0.84 0.20 1.00 0.98 0.79 0.73 0.28 0.85 0.30 0.54 0.47 0.48 0.44 0.28 0.45 0.49 1.00
4258 (MGST2) 0.65 0.64 0.22 0.53 0.32 0.68 0.75 0.73 0.69 0.73 0.51 0.51 0.61 0.45 0.54 0.63 0.76 0.49 0.49 0.40 0.40 0.40 1.00 0.38 0.40 0.89 0.43 0.90 1.00 0.43 0.44 0.38 1.00 0.74 0.21 1.00 0.90 0.75 0.69 0.27 0.80 0.29 0.50 0.45 0.47 0.42 0.27 0.44 0.46 1.00
1555 (CYP2B6) 0.36 0.38 0.22 0.35 0.30 0.41 0.40 0.48 0.39 0.48 0.92 0.91 0.38 0.65 0.71 0.35 0.41 0.77 0.36 0.28 0.28 0.28 0.45 0.76 0.28 0.51 0.93 0.44 0.43 1.00 0.81 0.94 0.33 0.31 0.21 0.33 0.46 0.54 0.54 0.35 0.43 0.36 0.72 0.46 0.83 0.89 0.34 0.91 0.36 0.33
1548 (CYP2A6) 0.49 0.39 0.17 0.29 0.26 0.44 0.45 0.52 0.51 0.50 0.84 0.85 0.40 0.55 0.57 0.47 0.48 0.69 0.40 0.21 0.21 0.21 0.35 0.58 0.21 0.39 0.74 0.46 0.44 0.81 1.00 0.87 0.25 0.25 0.17 0.25 0.47 0.55 0.52 0.28 0.53 0.29 0.79 0.45 0.63 0.70 0.27 0.69 0.41 0.25
1553 (CYP2A13) 0.34 0.34 0.18 0.31 0.28 0.38 0.38 0.45 0.37 0.43 0.84 0.85 0.36 0.56 0.62 0.32 0.39 0.70 0.33 0.21 0.21 0.21 0.35 0.69 0.21 0.39 0.87 0.40 0.38 0.94 0.87 1.00 0.25 0.26 0.17 0.25 0.41 0.48 0.47 0.28 0.40 0.31 0.72 0.40 0.73 0.83 0.27 0.84 0.35 0.25
653689 (GSTT2B) 1.00 0.23 0.24 0.23 0.23 0.23 1.00 0.23 1.00 0.27 0.41 0.41 1.00 0.41 0.41 1.00 1.00 0.41 0.40 0.40 0.40 0.40 0.23 0.33 0.40 0.27 0.33 1.00 1.00 0.33 0.25 0.25 1.00 1.00 0.24 1.00 1.00 1.00 1.00 0.24 1.00 0.24 0.25 0.24 0.41 0.33 0.24 0.33 0.24 1.00
2938 (GSTA1) 0.39 0.59 0.23 0.62 0.30 0.60 0.60 0.46 0.39 0.60 0.34 0.34 0.38 0.31 0.35 0.43 0.51 0.34 0.27 0.40 0.40 0.40 1.00 0.29 0.40 0.89 0.31 0.84 0.74 0.31 0.25 0.26 1.00 1.00 0.21 1.00 0.85 0.55 0.57 0.30 0.52 0.25 0.28 0.28 0.37 0.34 0.30 0.34 0.15 1.00
8836 (GGH) 0.16 0.17 0.31 0.19 0.19 0.17 0.20 0.17 0.17 0.20 0.24 0.24 0.17 0.22 0.25 0.17 0.19 0.25 0.61 0.20 0.20 0.20 0.20 0.20 0.20 0.23 0.22 0.20 0.21 0.21 0.17 0.17 0.24 0.21 1.00 0.24 0.21 0.25 0.26 0.18 0.17 0.16 0.19 0.18 0.25 0.23 0.19 0.23 0.13 0.24
221357 (GSTA5) 1.00 0.23 0.24 0.23 0.23 0.23 1.00 0.23 1.00 0.27 0.41 0.41 1.00 0.41 0.41 1.00 1.00 0.41 0.40 0.40 0.40 0.40 0.23 0.33 0.40 0.27 0.33 1.00 1.00 0.33 0.25 0.25 1.00 1.00 0.24 1.00 1.00 1.00 1.00 0.24 1.00 0.24 0.25 0.24 0.41 0.33 0.24 0.33 0.24 1.00
4259 (MGST3) 0.65 0.75 0.22 0.63 0.35 0.79 0.75 0.82 0.69 0.86 0.55 0.55 0.61 0.49 0.58 0.63 0.76 0.52 0.49 0.40 0.40 0.40 1.00 0.41 0.40 1.00 0.47 0.98 0.90 0.46 0.47 0.41 1.00 0.85 0.21 1.00 1.00 0.78 0.74 0.31 0.85 0.33 0.53 0.48 0.51 0.47 0.31 0.48 0.46 1.00
119391 (GSTO2) 0.73 0.53 0.25 0.39 0.43 0.65 0.77 0.66 0.73 0.67 0.68 0.67 0.66 0.63 0.72 0.67 0.83 0.65 0.55 0.40 0.40 0.40 0.56 0.51 0.40 0.62 0.55 0.79 0.75 0.54 0.55 0.48 1.00 0.55 0.25 1.00 0.78 1.00 0.94 0.39 0.75 0.39 0.64 0.62 0.65 0.57 0.37 0.57 0.55 1.00
9446 (GSTO1) 0.62 0.49 0.26 0.39 0.43 0.53 0.69 0.61 0.65 0.61 0.67 0.67 0.60 0.62 0.70 0.59 0.71 0.64 0.48 0.40 0.40 0.40 0.56 0.51 0.40 0.62 0.55 0.73 0.69 0.54 0.52 0.47 1.00 0.57 0.26 1.00 0.74 0.94 1.00 0.42 0.70 0.40 0.58 0.57 0.66 0.57 0.40 0.57 0.46 1.00
126 (ADH1C) 0.17 0.28 0.20 0.30 0.24 0.28 0.21 0.24 0.17 0.33 0.39 0.39 0.18 0.35 0.40 0.17 0.20 0.37 0.18 0.20 0.20 0.20 0.33 0.34 0.20 0.38 0.36 0.28 0.27 0.35 0.28 0.28 0.24 0.30 0.18 0.24 0.31 0.39 0.42 1.00 0.21 0.80 0.31 0.45 0.42 0.39 0.33 0.39 0.14 0.24
2946 (GSTM2) 0.88 0.59 0.17 0.42 0.28 0.69 0.75 0.74 0.92 0.73 0.56 0.56 0.70 0.50 0.58 0.88 0.77 0.54 0.57 0.40 0.40 0.40 1.00 0.39 0.40 0.89 0.43 0.85 0.80 0.43 0.53 0.40 1.00 0.52 0.17 1.00 0.85 0.75 0.70 0.21 1.00 0.28 0.57 0.53 0.45 0.42 0.20 0.43 0.69 1.00
130 (ADH6) 0.23 0.27 0.17 0.27 0.23 0.29 0.26 0.31 0.25 0.34 0.40 0.40 0.37 0.43 0.41 0.23 0.26 0.38 0.23 0.20 0.20 0.20 0.33 0.34 0.20 0.38 0.37 0.30 0.29 0.36 0.29 0.31 0.24 0.25 0.16 0.24 0.33 0.39 0.40 0.80 0.28 1.00 0.33 0.43 0.42 0.39 0.28 0.39 0.30 0.24
29785 (CYP2S1) 0.50 0.48 0.20 0.34 0.29 0.53 0.54 0.63 0.55 0.58 0.73 0.75 0.47 0.54 0.65 0.46 0.59 0.60 0.46 0.21 0.21 0.21 0.35 0.63 0.21 0.39 0.64 0.54 0.50 0.72 0.79 0.72 0.25 0.28 0.19 0.25 0.53 0.64 0.58 0.31 0.57 0.33 1.00 0.50 0.69 0.78 0.31 0.78 0.48 0.25
218 (ALDH3A1) 0.44 0.42 0.19 0.32 0.27 0.46 0.45 0.55 0.48 0.52 0.56 0.55 0.43 0.49 0.59 0.40 0.49 0.52 0.39 0.20 0.20 0.20 0.33 0.41 0.20 0.38 0.47 0.47 0.45 0.46 0.45 0.40 0.24 0.28 0.18 0.24 0.48 0.62 0.57 0.45 0.53 0.43 0.50 1.00 0.52 0.46 0.65 0.47 0.43 0.24
1559 (CYP2C9) 0.37 0.42 0.25 0.40 0.33 0.45 0.40 0.49 0.40 0.52 0.86 0.83 0.39 0.78 0.78 0.36 0.41 0.79 0.37 0.36 0.36 0.36 0.56 0.85 0.36 0.62 0.77 0.48 0.47 0.83 0.63 0.73 0.41 0.37 0.25 0.41 0.51 0.65 0.66 0.42 0.45 0.42 0.69 0.52 1.00 0.86 0.41 0.87 0.36 0.41
1572 (CYP2F1) 0.35 0.40 0.23 0.37 0.31 0.42 0.38 0.48 0.38 0.49 0.84 0.84 0.37 0.67 0.75 0.34 0.40 0.74 0.34 0.28 0.28 0.28 0.45 0.80 0.28 0.51 0.88 0.44 0.42 0.89 0.70 0.83 0.33 0.34 0.23 0.33 0.47 0.57 0.57 0.39 0.42 0.39 0.78 0.46 0.86 1.00 0.38 0.96 0.34 0.33
222 (ALDH3B2) 0.16 0.27 0.20 0.30 0.24 0.28 0.22 0.24 0.17 0.32 0.38 0.37 0.17 0.34 0.39 0.17 0.20 0.36 0.18 0.20 0.20 0.20 0.33 0.32 0.20 0.38 0.34 0.28 0.27 0.34 0.27 0.27 0.24 0.30 0.19 0.24 0.31 0.37 0.40 0.33 0.20 0.28 0.31 0.65 0.41 0.38 1.00 0.38 0.13 0.24
1562 (CYP2C18) 0.37 0.41 0.24 0.38 0.32 0.43 0.41 0.50 0.40 0.50 0.85 0.84 0.38 0.66 0.75 0.35 0.42 0.70 0.36 0.28 0.28 0.28 0.45 0.81 0.28 0.51 0.83 0.45 0.44 0.91 0.69 0.84 0.33 0.34 0.23 0.33 0.48 0.57 0.57 0.39 0.43 0.39 0.78 0.47 0.87 0.96 0.38 1.00 0.36 0.33
2937 (GSS) 0.72 0.37 0.13 0.22 0.22 0.51 0.52 0.55 0.72 0.49 0.43 0.43 0.67 0.40 0.47 0.67 0.60 0.42 0.48 0.20 0.20 0.20 0.20 0.31 0.20 0.23 0.37 0.49 0.46 0.36 0.41 0.35 0.24 0.15 0.13 0.24 0.46 0.55 0.46 0.14 0.69 0.30 0.48 0.43 0.36 0.34 0.13 0.36 1.00 0.24
2940 (GSTA3) 1.00 0.23 0.24 0.23 0.23 0.23 1.00 0.23 1.00 0.27 0.41 0.41 1.00 0.41 0.41 1.00 1.00 0.41 0.40 0.40 0.40 0.40 0.23 0.33 0.40 0.27 0.33 1.00 1.00 0.33 0.25 0.25 1.00 1.00 0.24 1.00 1.00 1.00 1.00 0.24 1.00 0.24 0.25 0.24 0.41 0.33 0.24 0.33 0.24 1.00
Association with High Altitude
Protein Official symbol Source Organism Tissue of Expression Level of hypoxia Altitude Duration of experiment Level of expression Fold change Experiment details geographical location ethnicity of the patients Control group Control (Fold change) Reference (PMID)
GSTP1 Toad Liver - 3464 m 33 day downregulated -7.67186632 RNA-seq Tibetan Plateau Asiatic toad 1 Zoige (High altitute Toad) Vs Chengdu (Low altitude toad) - 28673260
GSTP1 Human Muscle biopsies - 3500-4500 m 30 day downregulated 4.8 2-DE Himalayas Tibetan and nepali 1 Nepali controls residing at 1300m 14734630
GSTP1 Human Skeletal muscle - 4559 m 9 day upregulated -1.41 2-DIGE Southern Europe Italians 1 Fasting control subjects at laboratory in Copenhagen with no caffeine intake 18937252
GSTP1 Rat Kidney - 7628 m 7 day upregulated 3.55 2-DE Northern Indo-Australian Plate Male sprague-dawley 1 Male SD rats weighing 250-260g 30005088
Association with TF
TF TF Entrez Gene Gene Entrez Type PMID Database
FOXA1 3169 GSTP1 2950 proximal_filtered 22955619 TRANSFAC
SPI1 6688 GSTP1 2950 proximal_filtered 22955619 TRANSFAC
NFKB1 4790 GSTP1 2950 Unknown 19360354 TRUSST
JUN 3725 GSTP1 2950 Unknown 20692357 TRUSST
TP53 7157 GSTP1 2950 Repression 22120723 TRUSST
FOS 2353 GSTP1 2950 Unknown 23192983 TRUSST
SP1 6667 GSTP1 2950 Repression 21465172 TRUSST
CDX2 1045 GSTP1 2950 Activation 18941249 TRUSST
MBD2 8932 GSTP1 2950 Activation 23034409 TRUSST
RELA 5970 GSTP1 2950 Repression 22120723 TRUSST
Association with miRNA
miRTarBase ID miRNA Species (miRNA) Protein Official Symbol Human Entrez ID Species (Target Gene) Experiments Support Type References (PMID)
MIRT006966 hsa-miR-513a-3p Homo sapiens GSTP1 2950 Homo sapiens Luciferase reporter assay//qRT-PCR//Western blot Functional MTI 22749944
MIRT021715 hsa-miR-133a-3p Homo sapiens GSTP1 2950 Homo sapiens Reporter assay;Microarray Functional MTI 21396852
MIRT029320 hsa-miR-26b-5p Homo sapiens GSTP1 2950 Homo sapiens Microarray Functional MTI (Weak) 19088304
MIRT049201 hsa-miR-92a-3p Homo sapiens GSTP1 2950 Homo sapiens CLASH Functional MTI (Weak) 23622248
MIRT734781 hsa-miR-133b Homo sapiens GSTP1 2950 Homo sapiens Luciferase reporter assay Functional MTI 26396496
Gene Ontology
ID GO ID GO Term GO Type
2950 GO:0000302 response to reactive oxygen species GOTERM_BP_DIRECT
2950 GO:0009890 negative regulation of biosynthetic process GOTERM_BP_DIRECT
2950 GO:0006749 glutathione metabolic process GOTERM_BP_DIRECT
2950 GO:0043651 linoleic acid metabolic process GOTERM_BP_DIRECT
2950 GO:0032355 response to estradiol GOTERM_BP_DIRECT
2950 GO:0009636 response to toxic substance GOTERM_BP_DIRECT
2950 GO:0043124 negative regulation of I-kappaB kinase/NF-kappaB signaling GOTERM_BP_DIRECT
2950 GO:0071460 cellular response to cell-matrix adhesion GOTERM_BP_DIRECT
2950 GO:0045471 response to ethanol GOTERM_BP_DIRECT
2950 GO:0035731 Toll-like receptor 4 binding GOTERM_MF_DIRECT
2950 GO:0005622 intracellular GOTERM_CC_DIRECT
2950 GO:0005615 extracellular space GOTERM_CC_DIRECT
2950 GO:0005739 mitochondrion GOTERM_CC_DIRECT
2950 GO:0070062 extracellular exosome GOTERM_CC_DIRECT
2950 GO:0032872 regulation of stress-activated MAPK cascade GOTERM_BP_DIRECT
2950 GO:0033591 response to L-ascorbic acid GOTERM_BP_DIRECT
2950 GO:0035726 common myeloid progenitor cell proliferation GOTERM_BP_DIRECT
2950 GO:0043200 response to amino acid GOTERM_BP_DIRECT
2950 GO:0051771 negative regulation of nitric-oxide synthase biosynthetic process GOTERM_BP_DIRECT
2950 GO:0071672 negative regulation of smooth muscle cell chemotaxis GOTERM_BP_DIRECT
2950 GO:0070664 negative regulation of leukocyte proliferation GOTERM_BP_DIRECT
2950 GO:0004364 glutathione transferase activity GOTERM_MF_DIRECT
2950 GO:0035730 Toll-like receptor 4 binding GOTERM_MF_DIRECT
2950 GO:0043407 negative regulation of MAP kinase activity GOTERM_BP_DIRECT
2950 GO:0032720 negative regulation of tumor necrosis factor production GOTERM_BP_DIRECT
2950 GO:0005829 cytosol GOTERM_CC_DIRECT
2950 GO:0032873 negative regulation of stress-activated MAPK cascade GOTERM_BP_DIRECT
2950 GO:0048147 negative regulation of fibroblast proliferation GOTERM_BP_DIRECT
2950 GO:0004602 peroxidase activity GOTERM_MF_DIRECT
2950 GO:0043066 negative regulation of apoptotic process GOTERM_BP_DIRECT
2950 GO:0070373 negative regulation of ERK1 and ERK2 cascade GOTERM_BP_DIRECT
2950 GO:0071364 cellular response to epidermal growth factor stimulus GOTERM_BP_DIRECT
2950 GO:0070026 metalloaminopeptidase activity GOTERM_MF_DIRECT
2950 GO:0005737 cytoplasm GOTERM_CC_DIRECT
2950 GO:0014003 oligodendrocyte development GOTERM_BP_DIRECT
2950 GO:0006469 negative regulation of protein kinase activity GOTERM_BP_DIRECT
2950 GO:0010804 negative regulation of tumor necrosis factor-mediated signaling pathway GOTERM_BP_DIRECT
2950 GO:0043409 negative regulation of MAPK cascade GOTERM_BP_DIRECT
2950 GO:0070372 regulation of ERK1 and ERK2 cascade GOTERM_BP_DIRECT
2950 GO:0019207 mannokinase activity GOTERM_MF_DIRECT
2950 GO:0098869 cellular oxidant detoxification GOTERM_BP_DIRECT
2950 GO:0043295 laminin binding GOTERM_MF_DIRECT
2950 GO:0097057 TRAF2-GSTP1 complex GOTERM_CC_DIRECT
2950 GO:0071638 negative regulation of monocyte chemotactic protein-1 production GOTERM_BP_DIRECT
2950 GO:0016740 oxidoreductase activity GOTERM_MF_DIRECT
2950 GO:0032930 positive regulation of superoxide anion generation GOTERM_BP_DIRECT
2950 GO:0035732 nitric oxide storage GOTERM_BP_DIRECT
2950 GO:0008144 drug binding GOTERM_MF_DIRECT
2950 GO:0005886 plasma membrane GOTERM_CC_DIRECT
2950 GO:0006805 xenobiotic metabolic process GOTERM_BP_DIRECT
2950 GO:0008152 metabolic process GOTERM_BP_DIRECT
2950 GO:0007417 central nervous system development GOTERM_BP_DIRECT
2950 GO:0002674 negative regulation of acute inflammatory response GOTERM_BP_DIRECT
2950 GO:0031100 organ regeneration GOTERM_BP_DIRECT
2950 GO:1901687 glutathione derivative biosynthetic process GOTERM_BP_DIRECT
2950 GO:0032691 negative regulation of interleukin-1 beta production GOTERM_BP_DIRECT
2950 GO:0005634 nucleus GOTERM_CC_DIRECT
2950 GO:0071222 cellular response to lipopolysaccharide GOTERM_BP_DIRECT
2950 GO:0071385 cellular response to glucocorticoid stimulus GOTERM_BP_DIRECT
2950 GO:1904706 negative regulation of vascular smooth muscle cell proliferation GOTERM_BP_DIRECT
2950 GO:2001237 negative regulation of extrinsic apoptotic signaling pathway GOTERM_BP_DIRECT
2950 GO:0008432 phosphatidylethanolamine binding GOTERM_MF_DIRECT
2950 GO:0031982 vesicle GOTERM_CC_DIRECT
2950 GO:0032869 cellular response to insulin stimulus GOTERM_BP_DIRECT
2950 GO:0043508 negative regulation of JUN kinase activity GOTERM_BP_DIRECT
2950 GO:0005515 protein binding GOTERM_MF_DIRECT
Pathways
Human Entrez ID KEGG ID KEGG Term
2950 hsa00480 Glutathione metabolism
2950 hsa00982 Drug metabolism - cytochrome P450
2950 hsa00980 Metabolism of xenobiotics by cytochrome P450
2950 hsa05200 Pathways in cancer
2950 hsa05204 Chemical carcinogenesis
Association with Disease
Protein Official Symbol Human Entrez ID Disease Name Disease Id Disease Semantic Type Semantic score DSI DPI Disease Type
GSTP1 2950 Bladder Neoplasm C0005695 Neoplastic Process 0.6 0.406 0.828 group
GSTP1 2950 Malignant neoplasm of breast C0006142 Neoplastic Process 0.4 0.406 0.828 disease
GSTP1 2950 Autosome Abnormalities C0004403 Cell or Molecular Dysfunction 0.3 0.406 0.828 group
GSTP1 2950 Renal Cell Carcinoma C0007134 Neoplastic Process 0.36 0.406 0.828 disease
GSTP1 2950 Malignant neoplasm of urinary bladder C0005684 Neoplastic Process 0.59 0.406 0.828 disease
GSTP1 2950 Myocardial Ischemia C0151744 Disease or Syndrome 0.3 0.406 0.828 disease
GSTP1 2950 Contact hypersensitivity C0162351 Pathologic Function 0.3 0.406 0.828 phenotype
GSTP1 2950 Carcinoma, Spindle-Cell C0205697 Neoplastic Process 0.3 0.406 0.828 disease
GSTP1 2950 Familial Tremor C0393615 Disease or Syndrome 0.3 0.406 0.828 disease
GSTP1 2950 Kidney Diseases C0022658 Disease or Syndrome 0.3 0.406 0.828 group
GSTP1 2950 Psychoses, Drug C0033937 Mental or Behavioral Dysfunction 0.3 0.406 0.828 disease
GSTP1 2950 Wheezing C0043144 Sign or Symptom 0.4 0.406 0.828 phenotype
GSTP1 2950 Kidney Calculi C0022650 Disease or Syndrome 0.3 0.406 0.828 disease
GSTP1 2950 Kidney Failure, Acute C0022660 Disease or Syndrome 0.3 0.406 0.828 disease
GSTP1 2950 Mixed Cellularity Hodgkin Lymphoma C0152266 Neoplastic Process 0.3 0.406 0.828 disease
GSTP1 2950 Hepatoma, Novikoff C0019208 Experimental Model of Disease; Neoplastic Process 0.3 0.406 0.828 disease
GSTP1 2950 Amyotrophic Lateral Sclerosis, Guam Form C0543859 Disease or Syndrome 0.3 0.406 0.828 disease
GSTP1 2950 Chromophobe Renal Cell Carcinoma C1266042 Neoplastic Process 0.3 0.406 0.828 disease
GSTP1 2950 Lymphocyte Rich Classical Hodgkin Lymphoma C1266194 Neoplastic Process 0.3 0.406 0.828 disease
GSTP1 2950 Nonalcoholic Steatohepatitis C3241937 Disease or Syndrome 0.3 0.406 0.828 disease
GSTP1 2950 Hepatitis, Drug-Induced C1262760 Disease or Syndrome 0.3 0.406 0.828 disease
GSTP1 2950 Acute Kidney Insufficiency C1565662 Disease or Syndrome 0.3 0.406 0.828 disease
GSTP1 2950 Asthma C0004096 Disease or Syndrome 0.4 0.406 0.828 disease
GSTP1 2950 Autistic Disorder C0004352 Mental or Behavioral Dysfunction 0.32 0.406 0.828 group
GSTP1 2950 Carcinoma C0007097 Neoplastic Process 0.3 0.406 0.828 group
GSTP1 2950 Chromosome Aberrations C0008625 Cell or Molecular Dysfunction 0.3 0.406 0.828 group
GSTP1 2950 Drug Allergy C0013182 Pathologic Function 0.3 0.406 0.828 phenotype
GSTP1 2950 Hepatitis, Toxic C0019193 Injury or Poisoning 0.3 0.406 0.828 disease
GSTP1 2950 Lung Neoplasms C0024121 Neoplastic Process 0.6 0.406 0.828 group
GSTP1 2950 Amphetamine-Related Disorders C0236733 Mental or Behavioral Dysfunction 0.3 0.406 0.828 group
GSTP1 2950 Malignant neoplasm of lung C0242379 Neoplastic Process 0.6 0.406 0.828 disease
GSTP1 2950 Breast Carcinoma C0678222 Neoplastic Process 0.4 0.406 0.828 disease
GSTP1 2950 Hypertensive disease C0020538 Disease or Syndrome 0.31 0.406 0.828 group
GSTP1 2950 Malignant neoplasm of stomach C0024623 Neoplastic Process 0.4 0.406 0.828 disease
GSTP1 2950 Peripheral Neuropathy C0031117 Disease or Syndrome 0.32 0.406 0.828 group
GSTP1 2950 Carcinomatosis C0205699 Neoplastic Process 0.3 0.406 0.828 phenotype
GSTP1 2950 Adult Hodgkin Lymphoma C0220597 Neoplastic Process 0.3 0.406 0.828 disease
GSTP1 2950 mixed gliomas C0259783 Neoplastic Process 0.3 0.406 0.828 disease
GSTP1 2950 External Carotid Artery Diseases C0600178 Disease or Syndrome 0.3 0.406 0.828 group
GSTP1 2950 Parkinson Disease C0030567 Disease or Syndrome 0.36 0.406 0.828 disease
GSTP1 2950 Pleural Rub C0032230 Finding 0.3 0.406 0.828 phenotype
GSTP1 2950 Undifferentiated carcinoma C0205698 Neoplastic Process 0.3 0.406 0.828 phenotype
GSTP1 2950 Sarcoma, Spindle Cell C0205945 Neoplastic Process 0.3 0.406 0.828 disease
GSTP1 2950 Amphetamine Addiction C0236804 Mental or Behavioral Dysfunction 0.3 0.406 0.828 disease
GSTP1 2950 Carotid Artery Diseases C0007273 Disease or Syndrome 0.31 0.406 0.828 group
GSTP1 2950 Contact Dermatitis C0011616 Disease or Syndrome 0.3 0.406 0.828 disease
GSTP1 2950 Hepatoma, Morris C0019207 Experimental Model of Disease; Neoplastic Process 0.3 0.406 0.828 disease
GSTP1 2950 Hodgkin Disease C0019829 Neoplastic Process 0.35 0.406 0.828 disease
GSTP1 2950 Vestibular Diseases C0042594 Disease or Syndrome 0.3 0.406 0.828 group
GSTP1 2950 Sarcomatoid Renal Cell Carcinoma C1266043 Neoplastic Process 0.3 0.406 0.828 disease
GSTP1 2950 Arterial Diseases, Common Carotid C0750987 Disease or Syndrome 0.3 0.406 0.828 disease
GSTP1 2950 Ureteral Calculi C1456865 Disease or Syndrome 0.3 0.406 0.828 disease
GSTP1 2950 Non-Small Cell Lung Carcinoma C0007131 Neoplastic Process 0.4 0.406 0.828 disease
GSTP1 2950 Glioma C0017638 Neoplastic Process 0.39 0.406 0.828 disease
GSTP1 2950 Psychoses, Substance-Induced C0033941 Mental or Behavioral Dysfunction 0.3 0.406 0.828 disease
GSTP1 2950 Stomach Neoplasms C0038356 Neoplastic Process 0.31 0.406 0.828 group
GSTP1 2950 Stridor C0038450 Sign or Symptom 0.3 0.406 0.828 phenotype
GSTP1 2950 Anaplastic carcinoma C0205696 Neoplastic Process 0.3 0.406 0.828 disease
GSTP1 2950 Carotid Atherosclerosis C0577631 Disease or Syndrome 0.31 0.406 0.828 disease
GSTP1 2950 Malignant neoplasm of prostate C0376358 Neoplastic Process 0.4 0.406 0.828 disease
GSTP1 2950 Osteosarcoma C0029463 Neoplastic Process 0.34 0.406 0.828 disease
GSTP1 2950 Rhonchi C0035508 Finding 0.3 0.406 0.828 phenotype
GSTP1 2950 Rales C0034642 Finding 0.3 0.406 0.828 phenotype
GSTP1 2950 Condition, Preneoplastic C0282313 Neoplastic Process 0.3 0.406 0.828 phenotype
GSTP1 2950 Non-alcoholic Fatty Liver Disease C0400966 Disease or Syndrome 0.33 0.406 0.828 disease
GSTP1 2950 Internal Carotid Artery Diseases C0750986 Disease or Syndrome 0.3 0.406 0.828 disease
GSTP1 2950 Drug-Induced Acute Liver Injury C3658290 Disease or Syndrome 0.3 0.406 0.828 disease
GSTP1 2950 Hereditary Diffuse Gastric Cancer C1708349 Neoplastic Process 0.3 0.406 0.828 disease
GSTP1 2950 Amyotrophic Lateral Sclerosis C0002736 Disease or Syndrome 0.31 0.406 0.828 disease
GSTP1 2950 Necrosis C0027540 Organ or Tissue Function 0.3 0.406 0.828 phenotype
GSTP1 2950 Disease Exacerbation C0235874 Finding 0.3 0.406 0.828 phenotype
GSTP1 2950 Essential Tremor C0270736 Disease or Syndrome 0.31 0.406 0.828 disease
GSTP1 2950 Prostatic Intraepithelial Neoplasias C0282612 Neoplastic Process 0.4 0.406 0.828 disease
GSTP1 2950 Malignant Glioma C0555198 Neoplastic Process 0.3 0.406 0.828 disease
GSTP1 2950 Experimental Hepatoma C0086404 Experimental Model of Disease; Neoplastic Process 0.3 0.406 0.828 disease
GSTP1 2950 Amphetamine Abuse C0236807 Mental or Behavioral Dysfunction 0.3 0.406 0.828 disease
GSTP1 2950 Conventional (Clear Cell) Renal Cell Carcinoma C0279702 Neoplastic Process 0.3 0.406 0.828 disease
GSTP1 2950 Myeloid Leukemia, Chronic C0023473 Neoplastic Process 0.33 0.406 0.828 disease
GSTP1 2950 Hodgkin lymphoma, lymphocyte depletion C0152267 Neoplastic Process 0.3 0.406 0.828 disease
GSTP1 2950 Sarcoma, Epithelioid C0205944 Neoplastic Process 0.3 0.406 0.828 disease
GSTP1 2950 Amyotrophic Lateral Sclerosis With Dementia C0393554 Disease or Syndrome 0.3 0.406 0.828 disease
GSTP1 2950 Liver Neoplasms, Experimental C0023904 Experimental Model of Disease; Neoplastic Process 0.3 0.406 0.828 group
GSTP1 2950 Precancerous Conditions C0032927 Neoplastic Process 0.32 0.406 0.828 group
GSTP1 2950 Prostatic Neoplasms C0033578 Neoplastic Process 0.4 0.406 0.828 group
GSTP1 2950 Respiratory Sounds C0035234 Clinical Attribute 0.3 0.406 0.828 phenotype
GSTP1 2950 Collecting Duct Carcinoma of the Kidney C1266044 Neoplastic Process 0.3 0.406 0.828 disease
GSTP1 2950 Papillary Renal Cell Carcinoma C1306837 Neoplastic Process 0.31 0.406 0.828 disease
GSTP1 2950 Sarcoma C1261473 Neoplastic Process 0.31 0.406 0.828 group
GSTP1 2950 Chemical and Drug Induced Liver Injury C4277682 Disease or Syndrome 0.3 0.406 0.828 disease
GSTP1 2950 Mammary Neoplasms C1458155 Neoplastic Process 0.4 0.406 0.828 group
GSTP1 2950 Liver carcinoma C2239176 Neoplastic Process 0.4 0.406 0.828 disease
GSTP1 2950 Nodular Lymphocyte Predominant Hodgkin Lymphoma C1334968 Neoplastic Process 0.3 0.406 0.828 disease
GSTP1 2950 Mammary Neoplasms, Human C1257931 Neoplastic Process 0.3 0.406 0.828 group
GSTP1 2950 Acute kidney injury C2609414 Injury or Poisoning 0.3 0.406 0.828 disease
GSTP1 2950 Chemically-Induced Liver Toxicity C4279912 Disease or Syndrome 0.3 0.406 0.828 disease
GSTP1 2950 Drug-Induced Liver Disease C0860207 Disease or Syndrome 0.31 0.406 0.828 disease
GSTP1 2950 Acute Coronary Syndrome C0948089 Disease or Syndrome 0.3 0.406 0.828 disease
GSTP1 2950 Schizophrenia C0036341 Mental or Behavioral Dysfunction 0.36 0.406 0.828 disease
GSTP1 2950 Nonorganic psychosis C0349204 Mental or Behavioral Dysfunction 0.31 0.406 0.828 disease
GSTP1 2950 Psychotic Disorders C0033975 Mental or Behavioral Dysfunction 0.31 0.406 0.828 group
GSTP1 2950 Shared Paranoid Disorder C0036939 Mental or Behavioral Dysfunction 0.3 0.406 0.828 disease
GSTP1 2950 Cocaine Dependence C0600427 Mental or Behavioral Dysfunction 0.31 0.406 0.828 disease
Association with Drug
Protein Official Symbol Human Entrez ID drug_claim_primary_name drug_name drug_chembl_id interaction_types
GSTP1 2950 1-BETA-D-ARABINOFURANOSYLCYTOSINE CYTARABINE CHEMBL803 None
GSTP1 2950 5-AZADEOXYCYTIDINE DECITABINE CHEMBL1201129 None
GSTP1 2950 4-HYDROPEROXYCYCLOPHOSPHAMIDE PERFOSFAMIDE CHEMBL61511 None
GSTP1 2950 5-AZACYTIDINE AZACITIDINE CHEMBL1489 None
GSTP1 2950 ADM None None None
GSTP1 2950 ALPHA-TOCOPHEROL VITAMIN E CHEMBL47 None
GSTP1 2950 ADRIAMYCIN None None None
GSTP1 2950 AMB PRIDINOL CHEMBL404215 None
GSTP1 2950 ANDROGENS None None None
GSTP1 2950 BPDE None None None
GSTP1 2950 BUSULFAN BUSULFAN CHEMBL820 None
GSTP1 2950 BUTYRATE SODIUM BUTYRATE CHEMBL62381 None
GSTP1 2950 CAMPTOTHECIN CAMPTOTHECIN CHEMBL65 None
GSTP1 2950 CANFOSFAMIDE CANFOSFAMIDE CHEMBL2111086 None
GSTP1 2950 CARBOPLATIN CARBOPLATIN CHEMBL1351 None
GSTP1 2950 CARBOPLATIN CARBOPLATIN CHEMBL1351 None
GSTP1 2950 CISPLATIN None None None
GSTP1 2950 CISPLATIN None None None
GSTP1 2950 CPT-11 IRINOTECAN CHEMBL481 None
GSTP1 2950 CURCUMIN CURCUMIN CHEMBL116438 None
GSTP1 2950 CYCLOPHOSPHAMIDE CYCLOPHOSPHAMIDE CHEMBL88 None
GSTP1 2950 DEXAMETHASONE DEXAMETHASONE CHEMBL384467 None
GSTP1 2950 DIETHYLDITHIOCARBAMATE DITIOCARB CHEMBL961 None
GSTP1 2950 DNR DAUNORUBICIN CHEMBL178 None
GSTP1 2950 DOCETAXEL DOCETAXEL CHEMBL92 None
GSTP1 2950 DX-8951F EXATECAN MESYLATE CHEMBL2106563 None
GSTP1 2950 DROLOXIFENE DROLOXIFENE CHEMBL487 None
GSTP1 2950 ETHACRYNIC ACID ETHACRYNIC ACID CHEMBL456 None
GSTP1 2950 ETHANOL ALCOHOL CHEMBL545 None
GSTP1 2950 EZATIOSTAT EZATIOSTAT CHEMBL2110585 None
GSTP1 2950 EZATIOSTAT HYDROCHLORIDE EZATIOSTAT HYDROCHLORIDE CHEMBL2103810 inhibitor
GSTP1 2950 FOLFOXPROTOCOL None None None
GSTP1 2950 GARLIC GARLIC CHEMBL2108463 None
GSTP1 2950 HYDROQUINONE HYDROQUINONE CHEMBL537 None
GSTP1 2950 IFOSFAMIDE IFOSFAMIDE CHEMBL1024 None
GSTP1 2950 LYCOPENE LYCOPENE CHEMBL501174 None
GSTP1 2950 MELPHALAN MELPHALAN CHEMBL852 None
GSTP1 2950 MISONIDAZOLE MISONIDAZOLE CHEMBL42161 None
GSTP1 2950 NITROGEN MUSTARD MECHLORETHAMINE HYDROCHLORIDE CHEMBL1201001 None
GSTP1 2950 OXALIPLATIN OXALIPLATIN CHEMBL414804 None
GSTP1 2950 OMEPRAZOLE OMEPRAZOLE CHEMBL1503 None
GSTP1 2950 PACLITAXEL PACLITAXEL CHEMBL428647 None
GSTP1 2950 PEITC None None None
GSTP1 2950 PRED PREDNISONE CHEMBL635 None
GSTP1 2950 PREDNISONE PREDNISONE CHEMBL635 None
GSTP1 2950 RESVERATROL RESVERATROL CHEMBL165 None
GSTP1 2950 RU 486 MIFEPRISTONE CHEMBL1276308 None
GSTP1 2950 SELENOMETHIONINE SELENOMETHIONINE CHEMBL113178 None
GSTP1 2950 SULFORAPHANE SULFORAPHANE CHEMBL48802 None
GSTP1 2950 TOPOISOMERASE INHIBITORS None None None
GSTP1 2950 VERAPAMIL VERAPAMIL CHEMBL6966 None
GSTP1 2950 VITAMIN E VITAMIN E CHEMBL47 None